Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Bone Cells May Be Key to Controlling Diabetes- New Possible Treatment

Posted: Thursday, August 16, 2007

Researchers at Columbia University in New York have discovered that certain bone cells produce a hormone called osteocalcin, which influences beta-cell proliferation and controls the metabolism of blood sugar (glucose) and fat deposits through previously unknown mechanisms.  

The skeleton has long been seen as an inert scaffolding that gives the body shape and stability. But now researchers say bones appear to secrete a hormone that helps regulate sugar and fat — and that could have major implications for preventing or treating Type 2 diabetes.

 “It is very exciting conceptually because it's a new function for an organ,” senior author Dr. Gerard Karsenty said.. “It's also very exciting potentially from a medical point of view because it could be a treatment for Type 2 diabetes.”

In work in laboratory mice, the scientists show that bone-forming cells called osteoblasts release osteocalcin, which in turn increases both the secretion of insulin and insulin sensitivity. It also boosts the number of insulin-producing cells in the pancreas while reducing stores of fat.

All in all, that means the collection of femurs, ribs, clavicles and other bones that make up our skeleton aren't merely a framework for our various tissues, but an endocrine organ that helps control energy metabolism, said Dr. Karsenty, head of genetics at Columbia's school of medicine.

“These results uncover an important aspect of endocrinology that was unappreciated until now,” he said.

Dr. Karsenty and his colleagues, studied lab rats that had been genetically altered so their bodies did not produce osteocalcin.  “We realized that in the absence of osteocalcin, the mice were developing Type 2 diabetes and were overweight — not obese, but with increased fat mass — on a normal diet, which is rather unusual,” he said.

Most treatments for diabetes bump up insulin secretion to regulate blood sugar, but the problem is they also decrease insulin sensitivity, defined as the degree to which cells respond to a particular dose of insulin by lowering blood glucose levels.

While osteocalcin raises insulin production, it also bolsters insulin sensitivity at the same time, making it a potentially ideal treatment, said Dr. Karsenty, whose team is testing out injections of the hormone on different species to see if it could prevent or eliminate Type 2 diabetes.

“If it were (to work), the next species after that would be human beings.”
 

Source: Diabetes In Control: Published in August 10th edition of the journal Cell

 
 
 
 
 
Join us on Facebook
 
 
 

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement